Ideal Power Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
AUSTIN, Texas, Nov. 09, 2017 -- Ideal Power Inc. (NASDAQ:IPWR), an innovative power conversion technology company, reported results for the third quarter ending September 30, 2017. Key Third Quarter 2017 and...
Park City Group Reports Fiscal First Quarter 2018 Results
Nov 09, 2017 21:01 pm UTC| Business
Revenue Increased 12%, as Efforts Focused on Record ReposiTrak Backlog Operating Cash Flow Increased to $1.1 Million Leading to Record Cash Balance Management Reiterates Fiscal 2018 Revenue Growth Within Annual Target of...
Stemline Therapeutics Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial results for the...
Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 09, 2017 21:01 pm UTC| Business
Initiated a Phase 2 clinical trial with NasoVAX vaccine with initial data expected in first quarter 2018 Completed enrollment in its Phase 1 HepTcell clinical trial with data expected in fourth quarter 2017 Conference...
Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance
Nov 09, 2017 21:01 pm UTC| Business
MADISON, Wis., Nov. 09, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate performance for the...
Kona Grill Reports Third Quarter 2017 Results
Nov 09, 2017 21:01 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 09, 2017 -- Kona Grill, Inc. (NASDAQ:KONA), an American grill and sushi bar, reported financial results for the third quarter ended September 30, 2017. Third Quarter 2017 Key Items vs. Year-Ago...
Endocyte to Present at the Jefferies 2017 London Healthcare Conference
Nov 09, 2017 21:01 pm UTC| Business
WEST LAFAYETTE, Ind., Nov. 09, 2017 -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team...
FxWirePro- Major Economic Events for the day